Read the original article at soscip.org
Studio 1 Labs’ intelligent bed sheet will address some of the biggest challenges to Ontario’s healthcare system. The Toronto based start-up has developed a non-invasive wireless bed sheet that monitors respiratory rates and rhythms, heart rates, sleep patterns, location and movement; data which is traditionally collected via multiple devices. After successfully validating the bed sheet with the Internet of things (IoT), a technology which enables data to be collected and exchanged across multiple devices and platforms, phase two of the research continues in collaboration with Laura Nicholson, a Sessional Assistant Lecturer with York University School of Nursing and Program Director of Nursing Simulation Centre, to advance the development of sensory technologies for improved health outcomes. Assigned to help accelerate the development is SOSCIP post-doctoral fellow, Yevgeniy Davletshin.
Davletshin is a computational, biomedical, nuclear physicist who received his PhD in 2016 from Ryerson University. His extensive knowledge and expertise as a computational physicist caught the eye of Edward Shim, co-founder and managing director of Studio 1 Labs. “For machine learning and AI modelling I was specifically looking for a computational physicist,” says Shim. “Yevgeniy had a distinct personality that stood out above other candidates by expressing confidence in producing results prior to being selected, and that he could determine solutions in an area that required plenty of customization. The decision was confidently boosted by knowing there were plenty of expertise from SOSCIP to provide additional support if needed to develop quantifiable solutions in the global emerging industry of healthcare advanced analytics and AI.”
Davletshin is conducting clinical testing to validate the intelligent bed sheets with gold standard medical and IoT devices. While helping to refine the detection of heart rate, respiration and positioning data, his source of data is collected from the intelligent bed sheet, a continuous pulse oximeter and video analysis of movements and positioning of young adults. The clinical test compares the data from the intelligent bed sheet to a medical grade standard tool such as Health Canada approved pulse oximeter, a device that gauges the proportion of oxygenated hemoglobin in the blood in pulsating vessels. The bed sheet’s patent sensory technology is a game-changer for the healthcare industry. The use of such intelligent bed sheets presents new ways of working to improve patient’s healthcare outcomes and support healthcare practitioners by reducing healthcare expenditures with continuous monitoring for patient care efficiency.
“Yevgeniy has contributed by suggesting many various commercialization verticals, which provided defensibility as a company to have the ability to strategically pivot if or when needed, such as a triage management solution that mitigates risk of casualties that are critical from becoming fatal.”
Davletshin’s unique skill set has the ability to solve many challenges and take the textile sensors to the next level of advanced precision. For instance, another SOSCIP project is underway involving the development of artificial exterior skin to provide robotic applications with the equivalent to the human sense of touch to improve environmental monitoring in remote applications. “My work is concentrated on the application of deep learning algorithms for analysis of the vital sign signals, data analysis and mining to find new insights from the data collected by the bed sheet,” says Davletshin. The partnership development role established by SOSCIP was formative in providing the technical support and platforms best suited for the project’s requirements. When Davletshin required higher performing computations, SOSCIP was there to assist in transitioning him on to the GPU-Accelerated platform. “SOSCIP’s support was everywhere; it was a seamless integration,” says Davletshin.
Studio 1 Labs has grown through the many transitions typical of start-ups. The addition of Davletshin as a SOSCIP post-doctoral has positioned Studio 1 Labs further towards viable product development and commercialization for the first generation of non-invasive, clinical validated, patient monitoring solution with no attachments to the body. “Yevgeniy has contributed by suggesting many various commercialization verticals, which provided defensibility as a company to have the ability to strategically pivot if or when needed, such as a triage management solution that mitigates risk of casualties that are critical from becoming fatal,” Shim says. He adds, “The company is transforming into a digital platform that connects everyday soft items into connected health systems to improve patient care efficiency. This has become Studio 1 Labs’ global competitive advantage, all provided with the support of SOSCIP and the advanced computing platforms.